Compare ITRN & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITRN | LENZ |
|---|---|---|
| Founded | 1994 | 2019 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 854.8M | 852.0M |
| IPO Year | 2005 | 2021 |
| Metric | ITRN | LENZ |
|---|---|---|
| Price | $44.04 | $17.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $50.00 | ★ $56.25 |
| AVG Volume (30 Days) | 109.9K | ★ 1.1M |
| Earning Date | 11-18-2025 | 11-05-2025 |
| Dividend Yield | ★ 4.52% | N/A |
| EPS Growth | ★ 8.81 | N/A |
| EPS | ★ 2.84 | N/A |
| Revenue | ★ $348,409,000.00 | $17,500,000.00 |
| Revenue This Year | $9.12 | N/A |
| Revenue Next Year | $10.70 | $204.72 |
| P/E Ratio | $15.57 | ★ N/A |
| Revenue Growth | ★ 5.20 | N/A |
| 52 Week Low | $28.96 | $15.70 |
| 52 Week High | $45.43 | $50.40 |
| Indicator | ITRN | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 72.82 | 23.08 |
| Support Level | $39.24 | $15.70 |
| Resistance Level | $44.92 | $29.02 |
| Average True Range (ATR) | 1.14 | 2.37 |
| MACD | 0.43 | -0.92 |
| Stochastic Oscillator | 82.48 | 8.29 |
Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.